• TG003 and the Translational Logic of CLK2 Biology

  2026-09-01

  TG003 offers a reversible pharmacological route to interrogate Cdc2-like kinase biology, alternative splicing, and the CLK2–BRCA1 axis implicated in platinum resistance. This thought-leadership analysis connects splice-factor phosphorylation with translational study design while distinguishing validated evidence from forward-looking hypotheses.

• Quizartinib (AC220) Workflow for FLT3 Studies

  2026-09-01

  Build reproducible FLT3 pathway experiments with Quizartinib (AC220), from phospho-protein assays and AML cell viability studies to resistance-aware xenograft workflows. A cross-domain section uses recent norovirus–NINJ1 findings to sharpen assay controls without implying that Quizartinib directly regulates viral secretion.

• AA–HMF Co-exposure and Ferroptotic Gut Injury

  2026-08-31

  A 2026 Food Bioscience study shows that simultaneous exposure to acrylamide and 5-hydroxymethylfurfural damages IEC-6 intestinal epithelial cells through redox imbalance, mitochondrial dysfunction, and ferroptosis-associated signaling. Its combination of pharmacological rescue, molecular profiling, and transcriptomics provides a useful framework for distinguishing ferroptotic injury from general oxidative cytotoxicity.

• dhcr7 Knockout Grass Carp Shows GCRV Resistance

  2026-08-31

  A 2026 Aquaculture Reports study used CRISPR/Cas9 to disrupt dhcr7 in grass carp and found approximately 40% higher survival after GCRV-II challenge. The work links cholesterol biosynthesis with antiviral immunity in vivo, identifying dhcr7 as a disease-resistance breeding target without detectable penalties for growth or muscle morphology.

• A Broad-Spectrum mRNA Vaccine for Omicron and SARS-CoV

  2026-08-30

  Guan and colleagues engineered a lipid nanoparticle-encapsulated mRNA vaccine that replaces the mutable SARS-CoV-2 Omicron RBD with a conserved SARS-CoV RBD. In mice, this design generated cross-reactive neutralizing antibodies and protection against both Omicron and SARS-CoV, supporting antigen architecture as a strategy for broader coronavirus mRNA vaccine development.

• (S)-(+)-Methoprene Workflows for JH Research

  2026-08-29

  (S)-(+)-Methoprene is a practical juvenile hormone analog for separating receptor-driven developmental effects from upstream hormone-biosynthesis regulation. This workflow-focused guide shows how to pair Met activation with miRNA, transcriptional, developmental, and comparative receptor assays while avoiding common dosing and stability errors.

• Br-DAPI Workflows for DNA Imaging in Cardiac Models

  2026-08-28

  Br-DAPI combines membrane-permeable nuclear labeling with fluorescence amplification for flexible live-cell and fixed-cell analysis. This workflow applies it to palmitate-stressed cardiomyocytes, helping researchers normalize lipotoxicity assays while avoiding the common mistake of treating DNA signal as a direct apoptosis measurement.

• miR-18a, ALOXE3, and Ferroptosis in GBM

  2026-08-28

  This study defines a mechanistic link between miR-18a, ALOXE3-dependent lipid metabolism, ferroptosis resistance, and glioblastoma migration. Its key contribution is to connect an upstream microRNA with both tumor-cell survival and 12-HETE-driven signaling, providing a framework for studying how lipid metabolic changes shape GBM progression.

• CA-074 Me: Cathepsin B Inhibitor Workflows

  2026-08-27

  CA-074 Me enables cell-permeable inhibition of intracellular cathepsin B for dissecting lysosomal membrane permeabilization, necroptosis, and apoptosis-related phenotypes. This guide translates the MLKL–lysosome mechanism into practical imaging, inhibitor-control, and troubleshooting workflows while highlighting cathepsin L and solvent-related limitations.

• Mitochondrial Permeability Transition Pore Assay Kit Guide

  2026-08-27

  Translate mitochondrial injury into a measurable fluorescence signal with a Calcein AM fluorescent probe workflow designed for pore-opening studies. This guide connects assay setup, disease-model applications, and troubleshooting to the multiparameter findings reported in idiopathic carpal tunnel syndrome research.

• Prednisone as a Benchmark for Immune Assays

  2026-08-26

  Prednisone is a synthetic corticosteroid that enables mechanistically resolved studies of lymphocyte suppression and apoptosis. This article develops a benchmark strategy linking Prednisone-controlled immune assays with lessons from digestive LC–MS/MS metabolomics of botanical extracts.

• WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis

  2026-08-26

  This study identifies the WNT5a/GSK3/β-catenin axis as a major regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors. By integrating pharmacological screening, mass cytometry, animal models, and transcriptomic network analysis, it shows that GSK3 inhibition and restoration of WNT5a signaling can reduce pathological fat formation while improving FAP support for muscle regeneration.

• GANT61 Workflows for GLI-Driven Cancer Research

  2026-08-25

  GANT61 provides a practical, titratable route to suppress GLI1/2 activity in cancer models, with particular value for connecting Hedgehog-pathway signaling to ferroptosis and cisplatin response. This workflow translates recent bladder cancer findings into cell-based, mechanistic, combination-treatment, and xenograft study designs.

• CUDC-907: Practical Research Workflow

  2026-08-25

  CUDC-907 is a dual PI3K and HDAC inhibitor for controlled cell-based studies of PI3K/AKT signaling, HDAC activity, cell-cycle progression, and apoptosis. This guide provides starting conditions and QC practices for research workflows only; it is not a clinical, diagnostic, or therapeutic protocol.

• Berberine, RXRα/PPARγ, and SASP in Atherosclerosis

  2026-08-24

  The 2025 reference study identifies an RXRα/PPARγ/NEDD4 axis through which berberine suppresses SASP-associated inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse disease modeling, foam-cell assays, Smart-seq analysis, and macrophage-specific RXRα knockdown provides a mechanistic framework for studying receptor-dependent control of vascular inflammatory aging.

8023 records 1/535 page Next 12345 下5页 Last page